SUMMARY Antikeratin antibodies reacting in a laminar distribution with keratinised rat oesophagus were found in the sera of a proportion of patients with rheumatoid arthritis but not in healthy controls. In 
The keratins are a group offibrous insoluble proteins. Their inter-relationships are complex and they form a markedly heterogeneous group.' Experimental evidence for the antigenicity of these proteins was first reported in 1939 by Pillemer et al. 2 In 1979 Young et al.3 described the presence of antikeratin antibodies (AKA) in human sera reactive with the keratinised tissue of rat oesophagus. They showed that AKA were present in a significant proportion of patients with rheumatoid arthritis (RA) and they suggested AKA may be of diagnostic value in RA. We (Fig. 2) . Occasional sera from the patients with RA also showed diffuse or speckled staining of the superficial layers of the rat oesophagus. Diffuse staining of this kind was inconsistently related to the laminar pattern and varied markedly in intensity, sometimes being so weak and diffuse as to be difficult to distinguish from nonspecific background fluorescence. Since this pattern was easily distinguished, when it occurred, from the laminar pattern it was disregarded for the purposes of the present study.
AKA reactivity to keratin in the middle third of the rat oesophagus was present in 36 of the 99 patients with RA but none of the healthy controls (Table 1) . This is a highly significant finding (P<0 001). AKA reactivity at this site was titred in 6 randomly selected positive sera. Reactivity was detected to a titre of 1/80 in 3 cases, 1/320 in 1 case, and 1/640 in 2 cases.
AKA reactivity was found to vary with the anatomical site from which rat tissue was taken. The sera from some patients with RA reacted only with the keratin in the middle third of the oesophagus. Other sera gave positive reactions only at the gastrooesophageal junction, and other sera were reactive at both sites. These differences are summarised in Table 2 . Five sera from patients with RA with AKA reactivity to rat oesophagus were also examined for reactivity with homologous tissue, with sections of human skin being used as the test substrate. All 5 sera showed binding of IgG to human stratum corneum. The pattern of staining was broadly similar to that given by the same sera with rat oesophagus (Fig. 3) . All the other antitissue antibodies studied occurred with increased frequency in patients with RA who showed AKA reactivity to rat oesophagus, as shown in Table 3 . However, in view of the relatively small numbers involved there was no statistical correlation between AKA reactivity and any particular antitissue antibody. But on grouping together the results of tests for reactivity with reticulin, smooth muscle, gastric partietal cells, mitochondria, and nuclear components it was found that the 36 AKA positive sera gave positive reactions in 38 out of 180 tests for these antitissue antibodies as a group, whereas the 63 AKA negative sera contained these antibodies in only 41 out of 315 such tests, which is a significant difference (X2=5-60; DF=1; p<0 02). Similarly more AKA positive patients had positive sheep cell agglutination tests for IgM rheumatoid factor and had rheumatoid nodules (Table 4) .
There was no relationship between AKA positivity and clinical, haematological, and other parameters of disease activity in RA (Table 5) . Not only were none of these parameters statistically related to AKA reactivity but no clear pattern emerged on a detailed assessment of the results. For example, the Ritchie Haptoglobin (g/l)
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12-3 + 1. It was nevertheless interesting that, even after adopting this restriction, we encountered sera showing variable AKA reactivity between tissue taken from the oesophagus and from the gastrooesophageal junction. This suggested that differences may exist in the antigenicity, or in the access to antigenic determinants, of keratin at different sites. It was also of interest that the limited number of AKA-positive sera so far tested against an homologous tissue (human skin) have all shown reactivity with cells of the stratum corneum. We have not yet attempted the absorption of such sera with human skin homogenates to see whether reactivity to rat keratin is thus removed, but these experiments are planned and the results will be reported in due course.
Antibodies reactive with an undefined antigen of stratum corneum have been reported in a proportion of normal sera9 10 and with greatly increased frequency in patients with psoriasis"1-particularly psoriatics with erythroderma and arthritis.12 We have not yet had the opportunity to examine many sera from patients with psoriatic arthropathy, but on examining specimens from patients with another connective tissue disease often affecting the skin and upper alimentary tract, progressive systemic sclerosis, we have encountered a high proportion of AKA reactivity. This finding makes it clear that AKA reactivity is not 'disease specific' for RA.
In addition, although AKA reactivity was broadly related to the occurrence, in the same sera from RA patients, of other antitissue antibodies and showed some relation to IgM rheumatoid factor and rheumatoid nodules, yet 
